How To Use HCPCS Code C9783

HCPCS code C9783 describes a blinded procedure for transcatheter implantation of a coronary sinus reduction device or placebo control. This code is used to identify the specific procedure performed, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance, and supervision and interpretation when performed in an approved investigational device exemption (IDE) study.

1. What is HCPCS C9783?

HCPCS code C9783 is a specific code used in medical coding to identify a blinded procedure for transcatheter implantation of a coronary sinus reduction device or placebo control. It is important to note that this code is only applicable when performed in an approved investigational device exemption (IDE) study.

2. Official Description

The official description of HCPCS code C9783 is “Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (IDE) study.” The short description for this code is “Parenteral supp not othrws c.”

3. Procedure

1. The procedure begins with the placement of vascular access for the transcatheter implantation of the coronary sinus reduction device or placebo control.
2. Right heart catheterization is performed to assess the condition of the heart and determine the appropriate placement of the device.
3. Venous and coronary sinus angiography is conducted to visualize the blood vessels and coronary sinus.
4. The coronary sinus reduction device or placebo control is then implanted using transcatheter techniques.
5. Imaging guidance is utilized throughout the procedure to ensure accurate placement of the device.
6. Supervision and interpretation of the procedure are also included when performed in an approved investigational device exemption (IDE) study.
7. The procedure concludes with the closure of the vascular access site.

4. When to use HCPCS code C9783

HCPCS code C9783 should be used when performing a blinded procedure for transcatheter implantation of a coronary sinus reduction device or placebo control in an approved investigational device exemption (IDE) study. It is important to ensure that the procedure meets the specific criteria and guidelines set forth by the study protocol.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9783, healthcare providers should ensure that the necessary documentation is in place to support the medical necessity and appropriateness of the procedure. This may include detailed procedure notes, imaging reports, and any other relevant documentation. It is also important to follow the specific billing guidelines set forth by the payer, including any required modifiers or additional documentation.

6. Historical Information and Code Maintenance

HCPCS code C9783 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. As indicated by the action code N, no maintenance actions have been taken for this code. This means that there have been no updates or revisions since its addition to the coding system.

7. Medicare and Insurance Coverage

HCPCS code C9783 is assigned a pricing indicator code of 57, which indicates that it is priced by other carriers. The multiple pricing indicator code A signifies that it is not applicable as HCPCS priced under one methodology. Medicare coverage for this code may vary depending on the specific circumstances and guidelines set forth by the Centers for Medicare and Medicaid Services (CMS). It is important to check with the individual payer or insurance company for coverage and reimbursement information.

8. Examples

Here are five examples of when HCPCS code C9783 should be billed:

1. A patient participates in an approved investigational device exemption (IDE) study for the transcatheter implantation of a coronary sinus reduction device.
2. A healthcare provider performs a blinded procedure for the transcatheter implantation of a placebo control in an approved IDE study.
3. A patient undergoes right heart catheterization, venous and coronary sinus angiography, and the implantation of a coronary sinus reduction device as part of an approved IDE study.
4. A healthcare provider performs the procedure using imaging guidance and supervision in an approved IDE study.
5. A patient undergoes the closure of the vascular access site following the transcatheter implantation of a coronary sinus reduction device or placebo control in an approved IDE study.